Nanotamoxifen Delivery System: Toxicity Assessment After Oral Administration and Biodistribution Study After Intravenous Delivery of Radiolabeled Nanotamoxifen

Tamoxifen is the most prescribed anticancer oral drug for increasing overall survival and decreasing recurrence and the risk of contralateral disease. However, some side effects, such as endometrial and liver tumors, thromboembolic disorders, and drug resistance, are associated with long-term tamoxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Jaya, Dinda, Amit Kumar, Srivastava, Abhay Krishna, Srivastava, Kamna, Mittal, Bhagwant Rai, Bandopadhyaya, Guru Pad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729022/
https://www.ncbi.nlm.nih.gov/pubmed/26912972
http://dx.doi.org/10.4103/1450-1147.167594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729022/
https://www.ncbi.nlm.nih.gov/pubmed/26912972
http://dx.doi.org/10.4103/1450-1147.167594

Ejemplares similares